Back to top

Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session
January 07, 2014

Read MoreHide Full Article
Peregrine Pharmaceuticals, Inc. (PPHM - Free Report) was a big mover last session, as the company saw its shares rise over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up nearly 24% in the past one-month time frame.

The company has seen a mixed track record. There has been one upward revision and one downward revision over the past 30 days, while the Zacks Consensus Estimate has not been in a trend either. Yesterday’s price jump is encouraging though, so make sure to keep a close watch on this firm in the near future.
Peregrine Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

However, better-ranked stocks in the biomedicine/gene medical industry include Aastrom Biosciences, Inc. (), Gentium S.p.A () and Heska Corp. ((HSKA - Free Report) ). All these carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Peregrine Pharmaceuticals Inc. (PPHM) - free report >>

Heska Corporation (HSKA) - free report >>

More from Zacks Tale of the Tape

You May Like